Related Experiment Video
Updated: Jun 18, 2026

Detection of Functional Matrix Metalloproteinases by Zymography
Published on: November 8, 2010
Detection of in vivo matrix metalloproteinase activity using microdialysis sampling and liquid chromatography/mass
Ying Wang1, Dmitri V Zagorevski, Michelle R Lennartz
1Department of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, 110 Eighth Street, Troy, New York 12180, USA.
Abstract:
Matrix metalloproteinases (MMPs) are a family of endoproteases that break down extracellular matrix and whose upregulation contributes to several diseases. A liquid chromatography/tandem mass spectrometry (LC/MS/MS) method was developed to quantify MMP-1 and MMP-9 substrates and their N-terminal peptide products in samples obtained from implanted microdialysis sampling probes. In vitro studies with purified human MMP-1 and MMP-9 were used to optimize the assay and determine the effectiveness of the local delivery of a broad-spectrum MMP inhibitor, GM 6001. Localized delivery of GM 6001 at 10 microM was sufficient to completely inhibit product formation in vitro. In vivo studies in male Sprague-Dawley rats were performed with microdialysis probes implanted into the subcutaneous tissue. Directly after microdialysis probe implantation, infusions of the MMP-1 and MMP-9 substrates (50 microM each) resulted in recovered product concentrations of approximately 2 microM. During a 50 microM GM 6001 coinfusion with the substrates, a 30% and 25% reduction in product formation for the MMP-1 and MMP-9 substrates was obtained, respectively. Blank dialysates were negative for enzymatic activity that could cleave the MMP substrates. This method allowed for the activity of different MMPs surrounding the microdialysis probe to be observed during in vivo sampling.
Insights
A new method quantifies matrix metalloproteinase (MMP) activity using microdialysis. This technique measures MMP-1 and MMP-9 activity in vivo and assesses MMP inhibitor effectiveness.
Area of Science:
- Biochemistry
- Pharmacology
- Analytical Chemistry
Background:
- Matrix metalloproteinases (MMPs) are enzymes involved in extracellular matrix degradation.
- Upregulation of MMPs is linked to various pathological conditions.
- Developing methods to quantify MMP activity in vivo is crucial for disease research.
Purpose of the Study:
- To develop and validate a quantitative method for measuring MMP-1 and MMP-9 activity using microdialysis.
- To assess the efficacy of a broad-spectrum MMP inhibitor, GM 6001, in reducing MMP activity in vivo.
- To enable real-time observation of MMP activity surrounding microdialysis probes.
Main Methods:
- A liquid chromatography/tandem mass spectrometry (LC/MS/MS) assay was developed to quantify MMP substrates and their N-terminal peptide products.
- In vitro studies utilized purified human MMP-1 and MMP-9 to optimize the assay and test GM 6001.
- In vivo studies involved implanting microdialysis probes in rats and infusing MMP substrates with or without GM 6001.
Main Results:
- The LC/MS/MS method successfully quantified MMP-1 and MMP-9 products.
- In vitro, 10 microM GM 6001 completely inhibited product formation.
- In vivo, coinfusion of 50 microM GM 6001 reduced MMP-1 and MMP-9 substrate product formation by 30% and 25%, respectively.
Conclusions:
- The developed LC/MS/MS microdialysis method is effective for quantifying MMP activity in vivo.
- Localized delivery of GM 6001 demonstrates significant MMP inhibition in a subcutaneous implantation model.
- This assay provides a valuable tool for studying MMPs in physiological and pathological contexts.
Related Concept Videos
Matrix-Assisted Laser Desorption Ionization (MALDI)
MALDI-TOF Mass Spectrometry
Rapid Identification of Pathogens
Role of Matrix Metalloproteases in Degradation of ECM
A...

